/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

KALA BIO Inc Share Price Today: Live Updates & Key Insights

KALA BIO Inc share price today is $0.2334, up -3.7%. The stock opened at $0.2395 against the previous close of $0.2459, with an intraday high of $0.2403 and low of $0.2219.

KALA BIO Inc Share Price Chart

style
pb-0

KALA BIO Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

KALA BIO Inc Share Price Performance

$0.2334 -0.037(-3.7%) KALA at 23 Mar 2026 01:50 PM Biotechnology
Lowest Today 0.2219
Highest Today 0.2403
Today’s Open 0.2395
Prev. Close 0.2459
52 Week High 20.60
52 Week Low 0.22
Day’s Range: Low 0.2219 High 0.2403
52-Week Range: Low 0.22 High 20.60
1 day return -
1 Week return -11.26
1 month return -38.0
3 month return -60.09
6 month return -98.72
1 year return -96.45
3 year return -98.3
5 year return -99.94
10 year return -

KALA BIO Inc Institutional Holdings

Baker Bros Advisors LP 0.20

Woodline Partners LP 0.02

Jane Street Group LLC 0.02

ADAR1 Capital Management LLC 0.02

Vanguard Group Inc 0.01

Geode Capital Management, LLC 0.01

Vanguard Institutional Extnd Mkt Idx Tr 0.01

Citadel Advisors Llc 0.01

Renaissance Technologies Corp 0.00

Fidelity Extended Market Index 0.00

State Street Corp 0.00

Two Sigma Investments LLC 0.00

BlackRock Inc 0.00

Marex Group PLC 0.00

TWO SIGMA SECURITIES, LLC 0.00

Fidelity Total Market Index 0.00

Northern Trust Corp 0.00

Blackrock Extended Mkt Fund CF 0.00

Extended Equity Market Fund K 0.00

UBS Group AG 0.00

Fidelity Series Total Market Index 0.00

Fidelity Nasdaq Composite Index 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Spartan Total Market Index Pool G 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Bank of America Corp 0.00

Morgan Stanley - Brokerage Accounts 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

Blackrock US Eq Mkt Fund CF 0.00

Citigroup Inc 0.00

Covestor Ltd 0.00

Extended Equity Market Fund M 0.00

JHVIT Total Stock Market Index I 0.00

SSgA U.S. Total Market Index Strategy 0.00

U.S. Equity Market Fund F 0.00

Vanguard U.S. Eq Idx £ Acc 0.00

Mccormack Advisors International 0.00

KALA BIO Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

KALA BIO Inc Fundamentals

Market Cap 215.80 M

PB Ratio 1.9762

PE Ratio 0.0

Enterprise Value 224.65 M

Total Assets 55.48 M

Volume 2698712

KALA BIO Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:3892000 3.9M, FY21:11240000 11.2M, FY20:6362000 6.4M, FY19:6074000 6.1M

Annual Profit FY23:0 0.0M, FY22:1332000 1.3M, FY21:7143000 7.1M, FY20:3189000 3.2M, FY19:4066000 4.1M

Annual Net worth FY23:-46415000 -46.4M, FY22:-223000 -0.2M, FY21:-152296000 -152.3M, FY20:-112004000 -112.0M, FY19:-101984000 -102.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-67000 -0.1M, Q1/2025:-68000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-61000 -0.1M

Quarterly Net worth Q3/2025:-7564000 -7.6M, Q2/2025:-11155000 -11.2M, Q1/2025:-8947000 -8.9M, Q3/2024:-8950000 -9.0M, Q2/2024:-9579000 -9.6M

About KALA BIO Inc & investment objective

Company Information KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

Organisation Biotechnology

Employees 38

Industry Biotechnology

CEO Mr. Avi Minkowitz

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

KALA BIO Inc FAQs

What is the share price of KALA BIO Inc today?

The current share price of KALA BIO Inc is $0.2334.

Can I buy KALA BIO Inc shares in India?

Yes, Indian investors can buy KALA BIO Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy KALA BIO Inc shares in India?

You can easily invest in KALA BIO Inc shares from India by:

Can I buy fractional shares of KALA BIO Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of KALA BIO Inc?

KALA BIO Inc has a market cap of $215.80 M.

In which sector does KALA BIO Inc belong?

KALA BIO Inc operates in the Biotechnology sector.

What documents are required to invest in KALA BIO Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of KALA BIO Inc?

The PE ratio of KALA BIO Inc is N/A and the PB ratio is 1.98.